EI
AGN

Ethic Inc’s Allergan plc AGN Stock Holding History

Ethic Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,141
Closed -$556K – 290
2020
Q1 		$556K Buy
3,141
+210
+7% +$39.5K 0.46% 63
2019
Q4 		$560K Buy
+2,931
New +$529K 0.41% 81

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ethic Inc's AGN Position: Q2 2020 in Review

Ethic Inc sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,141 shares — an estimated $556K sold.

Ethic Inc first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $560K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ethic Inc reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ethic Inc sold 3,141 Allergan plc shares in Q2 2020, an estimated $556K.
  • Ethic Inc first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Ethic Inc's Allergan plc position peaked at $560K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ethic Inc's 13F filing for Q2 2020, filed 12 Aug 2020.